![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ParAllele BioScience Announces Key Patent Issuance
ParAllele BioScience Announces Key Patent Issuance
ParAllele BioScience has announced the issuance by the U.S. Patent Office of a key patent (6,858,412) covering its Molecular Inversion Probe (MIP) technology. The patent is owned by Stanford University and is exclusively licensed to ParAllele. The patent protects detection of genetic sequences by formation circularized probes that are subsequently linearized and amplified for detection.
News-Medical.Net (http://www.news-medical.net/?id=8587)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct